IBDEI0DU ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13836,1,4,0)
 ;;=4^I71.2
 ;;^UTILITY(U,$J,358.3,13836,2)
 ;;=^5007787
 ;;^UTILITY(U,$J,358.3,13837,0)
 ;;=I71.4^^61^727^1
 ;;^UTILITY(U,$J,358.3,13837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13837,1,3,0)
 ;;=3^Abdominal Aortic Aneurysm w/o Rupture
 ;;^UTILITY(U,$J,358.3,13837,1,4,0)
 ;;=4^I71.4
 ;;^UTILITY(U,$J,358.3,13837,2)
 ;;=^5007789
 ;;^UTILITY(U,$J,358.3,13838,0)
 ;;=I73.9^^61^727^19
 ;;^UTILITY(U,$J,358.3,13838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13838,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,13838,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,13838,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,13839,0)
 ;;=I82.891^^61^727^14
 ;;^UTILITY(U,$J,358.3,13839,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13839,1,3,0)
 ;;=3^Embolism/Thrombosis Oth Spec Veins,Chronic
 ;;^UTILITY(U,$J,358.3,13839,1,4,0)
 ;;=4^I82.891
 ;;^UTILITY(U,$J,358.3,13839,2)
 ;;=^5007939
 ;;^UTILITY(U,$J,358.3,13840,0)
 ;;=I82.890^^61^727^13
 ;;^UTILITY(U,$J,358.3,13840,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13840,1,3,0)
 ;;=3^Embolism/Thrombosis Oth Spec Veins,Acute
 ;;^UTILITY(U,$J,358.3,13840,1,4,0)
 ;;=4^I82.890
 ;;^UTILITY(U,$J,358.3,13840,2)
 ;;=^5007938
 ;;^UTILITY(U,$J,358.3,13841,0)
 ;;=E78.0^^61^728^12
 ;;^UTILITY(U,$J,358.3,13841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13841,1,3,0)
 ;;=3^Pure Hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,13841,1,4,0)
 ;;=4^E78.0
 ;;^UTILITY(U,$J,358.3,13841,2)
 ;;=^5002966
 ;;^UTILITY(U,$J,358.3,13842,0)
 ;;=E78.1^^61^728^13
 ;;^UTILITY(U,$J,358.3,13842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13842,1,3,0)
 ;;=3^Pure Hyperglyceridemia
 ;;^UTILITY(U,$J,358.3,13842,1,4,0)
 ;;=4^E78.1
 ;;^UTILITY(U,$J,358.3,13842,2)
 ;;=^101303
 ;;^UTILITY(U,$J,358.3,13843,0)
 ;;=E78.2^^61^728^11
 ;;^UTILITY(U,$J,358.3,13843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13843,1,3,0)
 ;;=3^Mixed Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,13843,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,13843,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,13844,0)
 ;;=I10.^^61^728^3
 ;;^UTILITY(U,$J,358.3,13844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13844,1,3,0)
 ;;=3^Essential Primary Hypertension
 ;;^UTILITY(U,$J,358.3,13844,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,13844,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,13845,0)
 ;;=I11.9^^61^728^10
 ;;^UTILITY(U,$J,358.3,13845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13845,1,3,0)
 ;;=3^Hypertensive Heart Disease w/o Heart Failure
 ;;^UTILITY(U,$J,358.3,13845,1,4,0)
 ;;=4^I11.9
 ;;^UTILITY(U,$J,358.3,13845,2)
 ;;=^5007064
 ;;^UTILITY(U,$J,358.3,13846,0)
 ;;=I11.0^^61^728^9
 ;;^UTILITY(U,$J,358.3,13846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13846,1,3,0)
 ;;=3^Hypertensive Heart Disease w/ Heart Failure
 ;;^UTILITY(U,$J,358.3,13846,1,4,0)
 ;;=4^I11.0
 ;;^UTILITY(U,$J,358.3,13846,2)
 ;;=^5007063
 ;;^UTILITY(U,$J,358.3,13847,0)
 ;;=I12.0^^61^728^8
 ;;^UTILITY(U,$J,358.3,13847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13847,1,3,0)
 ;;=3^Hypertensive Chr Kidney Disease w/ ESRD
 ;;^UTILITY(U,$J,358.3,13847,1,4,0)
 ;;=4^I12.0
 ;;^UTILITY(U,$J,358.3,13847,2)
 ;;=^5007065
 ;;^UTILITY(U,$J,358.3,13848,0)
 ;;=I13.10^^61^728^6
 ;;^UTILITY(U,$J,358.3,13848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13848,1,3,0)
 ;;=3^HTN Hrt & Chr Kdny Dis w/o Hrt Fail w/ Stg 1-4 Chr Kdny
 ;;^UTILITY(U,$J,358.3,13848,1,4,0)
 ;;=4^I13.10
 ;;^UTILITY(U,$J,358.3,13848,2)
 ;;=^5007068
 ;;^UTILITY(U,$J,358.3,13849,0)
 ;;=I13.0^^61^728^4
 ;;^UTILITY(U,$J,358.3,13849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13849,1,3,0)
 ;;=3^HTN Hrt & Chr Kdny Dis w/ Hrt Fail w/ Stg 1-4 Chr Kdny
 ;;^UTILITY(U,$J,358.3,13849,1,4,0)
 ;;=4^I13.0
 ;;^UTILITY(U,$J,358.3,13849,2)
 ;;=^5007067
 ;;^UTILITY(U,$J,358.3,13850,0)
 ;;=I13.11^^61^728^7
 ;;^UTILITY(U,$J,358.3,13850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13850,1,3,0)
 ;;=3^HTN Hrt & Chr Kdny Dis w/o Hrt Fail w/ Stg 5 Chr Kdny
 ;;^UTILITY(U,$J,358.3,13850,1,4,0)
 ;;=4^I13.11
 ;;^UTILITY(U,$J,358.3,13850,2)
 ;;=^5007069
 ;;^UTILITY(U,$J,358.3,13851,0)
 ;;=I13.2^^61^728^5
 ;;^UTILITY(U,$J,358.3,13851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13851,1,3,0)
 ;;=3^HTN Hrt & Chr Kdny Dis w/ Hrt Fail w/ Stg 5 Chr Kdny
 ;;^UTILITY(U,$J,358.3,13851,1,4,0)
 ;;=4^I13.2
 ;;^UTILITY(U,$J,358.3,13851,2)
 ;;=^5007070
 ;;^UTILITY(U,$J,358.3,13852,0)
 ;;=I48.91^^61^728^1
 ;;^UTILITY(U,$J,358.3,13852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13852,1,3,0)
 ;;=3^Atrial Fibrillation,Unspec
 ;;^UTILITY(U,$J,358.3,13852,1,4,0)
 ;;=4^I48.91
 ;;^UTILITY(U,$J,358.3,13852,2)
 ;;=^5007229
 ;;^UTILITY(U,$J,358.3,13853,0)
 ;;=I48.92^^61^728^2
 ;;^UTILITY(U,$J,358.3,13853,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13853,1,3,0)
 ;;=3^Atrial Flutter,Unspec
 ;;^UTILITY(U,$J,358.3,13853,1,4,0)
 ;;=4^I48.92
 ;;^UTILITY(U,$J,358.3,13853,2)
 ;;=^5007230
 ;;^UTILITY(U,$J,358.3,13854,0)
 ;;=B07.9^^61^729^288
 ;;^UTILITY(U,$J,358.3,13854,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13854,1,3,0)
 ;;=3^Viral Wart,Unspec
 ;;^UTILITY(U,$J,358.3,13854,1,4,0)
 ;;=4^B07.9
 ;;^UTILITY(U,$J,358.3,13854,2)
 ;;=^5000519
 ;;^UTILITY(U,$J,358.3,13855,0)
 ;;=A63.0^^61^729^34
 ;;^UTILITY(U,$J,358.3,13855,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13855,1,3,0)
 ;;=3^Anogenital (Venereal) Warts
 ;;^UTILITY(U,$J,358.3,13855,1,4,0)
 ;;=4^A63.0
 ;;^UTILITY(U,$J,358.3,13855,2)
 ;;=^5000360
 ;;^UTILITY(U,$J,358.3,13856,0)
 ;;=B35.0^^61^729^279
 ;;^UTILITY(U,$J,358.3,13856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13856,1,3,0)
 ;;=3^Tinea Barbae and Tinea Capitis
 ;;^UTILITY(U,$J,358.3,13856,1,4,0)
 ;;=4^B35.0
 ;;^UTILITY(U,$J,358.3,13856,2)
 ;;=^5000604
 ;;^UTILITY(U,$J,358.3,13857,0)
 ;;=B35.1^^61^729^284
 ;;^UTILITY(U,$J,358.3,13857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13857,1,3,0)
 ;;=3^Tinea Unguium
 ;;^UTILITY(U,$J,358.3,13857,1,4,0)
 ;;=4^B35.1
 ;;^UTILITY(U,$J,358.3,13857,2)
 ;;=^119748
 ;;^UTILITY(U,$J,358.3,13858,0)
 ;;=B35.6^^61^729^281
 ;;^UTILITY(U,$J,358.3,13858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13858,1,3,0)
 ;;=3^Tinea Cruris
 ;;^UTILITY(U,$J,358.3,13858,1,4,0)
 ;;=4^B35.6
 ;;^UTILITY(U,$J,358.3,13858,2)
 ;;=^119711
 ;;^UTILITY(U,$J,358.3,13859,0)
 ;;=B35.3^^61^729^283
 ;;^UTILITY(U,$J,358.3,13859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13859,1,3,0)
 ;;=3^Tinea Pedis
 ;;^UTILITY(U,$J,358.3,13859,1,4,0)
 ;;=4^B35.3
 ;;^UTILITY(U,$J,358.3,13859,2)
 ;;=^119732
 ;;^UTILITY(U,$J,358.3,13860,0)
 ;;=B35.5^^61^729^282
 ;;^UTILITY(U,$J,358.3,13860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13860,1,3,0)
 ;;=3^Tinea Imbricata
 ;;^UTILITY(U,$J,358.3,13860,1,4,0)
 ;;=4^B35.5
 ;;^UTILITY(U,$J,358.3,13860,2)
 ;;=^119725
 ;;^UTILITY(U,$J,358.3,13861,0)
 ;;=B35.4^^61^729^280
 ;;^UTILITY(U,$J,358.3,13861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13861,1,3,0)
 ;;=3^Tinea Corporis
 ;;^UTILITY(U,$J,358.3,13861,1,4,0)
 ;;=4^B35.4
 ;;^UTILITY(U,$J,358.3,13861,2)
 ;;=^119704
 ;;^UTILITY(U,$J,358.3,13862,0)
 ;;=B35.8^^61^729^137
 ;;^UTILITY(U,$J,358.3,13862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13862,1,3,0)
 ;;=3^Dermatophytoses,Other
 ;;^UTILITY(U,$J,358.3,13862,1,4,0)
 ;;=4^B35.8
 ;;^UTILITY(U,$J,358.3,13862,2)
 ;;=^5000606
 ;;^UTILITY(U,$J,358.3,13863,0)
 ;;=B36.9^^61^729^272
 ;;^UTILITY(U,$J,358.3,13863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13863,1,3,0)
 ;;=3^Superficial Mycosis,Unspec
 ;;^UTILITY(U,$J,358.3,13863,1,4,0)
 ;;=4^B36.9
 ;;^UTILITY(U,$J,358.3,13863,2)
 ;;=^5000611
 ;;^UTILITY(U,$J,358.3,13864,0)
 ;;=D69.0^^61^729^32
 ;;^UTILITY(U,$J,358.3,13864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13864,1,3,0)
 ;;=3^Allergic Purpura
 ;;^UTILITY(U,$J,358.3,13864,1,4,0)
 ;;=4^D69.0
 ;;^UTILITY(U,$J,358.3,13864,2)
 ;;=^5002365
 ;;^UTILITY(U,$J,358.3,13865,0)
 ;;=B00.9^^61^729^158
